| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1028706706 |
| P356 | DOI | 10.1186/1479-5876-12-38 |
| P932 | PMC publication ID | 3923730 |
| P698 | PubMed publication ID | 24507657 |
| P5875 | ResearchGate publication ID | 260129345 |
| P2093 | author name string | Jean-Louis Abitbol | |
| Patrick Berna | |||
| Sophie Schaller | |||
| Alain Berdeaux | |||
| Jean Afxantidis | |||
| Magali Michaud | |||
| Marcel Culcasi | |||
| Sylvia Pietri | |||
| Yves Donazzolo | |||
| Didier Morin | |||
| Stéphanie Paradis | |||
| Hidayat Rahmouni | |||
| Corinne Chaimbault | |||
| Mathilde Latreille | |||
| Sophie Le Lamer | |||
| Rebacca M Pruss | |||
| P2860 | cites work | Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles | Q33375795 |
| Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators | Q34539986 | ||
| Peripheral benzodiazepine receptor-induced myocardial protection is mediated by inhibition of mitochondrial membrane permeabilization | Q34653787 | ||
| Myocardial reperfusion injury. | Q34687124 | ||
| Ginkgo biloba extract (EGb 761) pretreatment limits free radical-induced oxidative stress in patients undergoing coronary bypass surgery | Q34740017 | ||
| Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity | Q36248358 | ||
| Calcium, mitochondria and reperfusion injury: a pore way to die. | Q36424289 | ||
| Inhibition of mitochondrial permeability transition pore opening: translation to patients | Q37394436 | ||
| The radical trap 5,5-dimethyl-1-pyrroline N-oxide exerts dose-dependent protection against myocardial ischemia-reperfusion injury through preservation of mitochondrial electron transport | Q41953172 | ||
| Heart protection and radical trapping by DMPO during reperfusion in isolated working rat hearts | Q42070657 | ||
| Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress | Q42818406 | ||
| TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition. | Q43136849 | ||
| Mitochondrial calcium in health and disease | Q43288827 | ||
| The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial | Q43796510 | ||
| Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions | Q44572721 | ||
| Time to take myocardial reperfusion injury seriously | Q46453587 | ||
| Effect of cyclosporine on reperfusion injury in acute myocardial infarction | Q46453592 | ||
| Postconditioning the human heart | Q46722557 | ||
| Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. | Q51808889 | ||
| Rationale and Design of the MITOCARE Study: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRO40303 for the Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coro | Q57572076 | ||
| Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues. | Q64970631 | ||
| Ascorbyl free radical as a reliable indicator of free-radical-mediated myocardial ischemic and post-ischemic injury. A real-time continuous-flow ESR study | Q68487724 | ||
| Myocardial cell protection : a challenging time for action and a challenging time for clinical research | Q73929735 | ||
| Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction | Q74332512 | ||
| New perspectives on the cardioprotective phosphonate effect of the spin trap 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline N-oxide: an hemodynamic and 31P NMR study in rat hearts | Q78115602 | ||
| Liposome-mediated triggering of complement cascade | Q81814612 | ||
| AMISTAD trials: possible reasons for lack of success | Q82871131 | ||
| Cardiac protection takes off | Q84030433 | ||
| Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome | Q84444951 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phase I clinical trial | Q5452194 |
| myocardial infarction | Q12152 | ||
| P304 | page(s) | 38 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Journal of Translational Medicine | Q15716664 |
| P1476 | title | Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial | |
| P478 | volume | 12 |
| Q50560471 | Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins. |
| Q34056025 | Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons |
| Q54325677 | Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results. |
| Q53836881 | Estrogen receptor beta modulates permeability transition in brain mitochondria. |
| Q30491901 | Exosomes From Adipose-derived Mesenchymal Stem Cells Protect the Myocardium Against Ischemia/Reperfusion Injury Through Wnt/β-Catenin Signaling Pathway |
| Q36203942 | Identification of ER-000444793, a Cyclophilin D-independent inhibitor of mitochondrial permeability transition, using a high-throughput screen in cryopreserved mitochondria |
| Q64886537 | Mitochondrial Membrane Permeability Inhibitors in Acute Myocardial Infarction: Still Awaiting Translation. |
| Q92356830 | New insights into acute pancreatitis |
| Q91860378 | Pharmacology of mitochondrial permeability transition pore inhibitors |
| Q49771122 | TRO40303 Ameliorates Alcohol-Induced Pancreatitis Through Reduction of Fatty Acid Ethyl Ester-Induced Mitochondrial Injury and Necrotic Cell Death |
| Q41359580 | TRO40303, a mitochondrial-targeted cytoprotective compound, provides protection in hepatitis models |
| Q91276580 | Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles |
| Q38445775 | The mitochondrial translocator protein and arrhythmogenesis in ischemic heart disease |
| Q92847557 | Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST-segment elevation myocardial infarction |
| Q38809524 | Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010 - 2015; part 2). |
Search more.